239 related articles for article (PubMed ID: 33255261)
1. Receptor Binding Domains of TcdB from
Henkel D; Tatge H; Schöttelndreier D; Tao L; Dong M; Gerhard R
Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255261
[TBL] [Abstract][Full Text] [Related]
2. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
[TBL] [Abstract][Full Text] [Related]
3. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
4. Low-density lipoprotein receptor-related protein 1 is a CROPs-associated receptor for Clostridioides infection toxin B.
Guo S; Chen Y; Liu J; Zhang X; Liu Z; Zhou Z; Wei W
Sci China Life Sci; 2022 Jan; 65(1):107-118. PubMed ID: 34279819
[TBL] [Abstract][Full Text] [Related]
5. Structural dynamics of receptor recognition and pH-induced dissociation of full-length Clostridioides difficile Toxin B.
Jiang M; Shin J; Simeon R; Chang JY; Meng R; Wang Y; Shinde O; Li P; Chen Z; Zhang J
PLoS Biol; 2022 Mar; 20(3):e3001589. PubMed ID: 35324891
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease.
Larabee JL; Doyle DA; Ahmed UKB; Shadid TM; Sharp RR; Jones KL; Kim YM; Li S; Ballard JD
PLoS Pathog; 2023 Mar; 19(3):e1011272. PubMed ID: 36972308
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection.
Chen P; Zeng J; Liu Z; Thaker H; Wang S; Tian S; Zhang J; Tao L; Gutierrez CB; Xing L; Gerhard R; Huang L; Dong M; Jin R
Nat Commun; 2021 Jun; 12(1):3748. PubMed ID: 34145250
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
[TBL] [Abstract][Full Text] [Related]
9. Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B.
Simeon R; Jiang M; Chamoun-Emanuelli AM; Yu H; Zhang Y; Meng R; Peng Z; Jakana J; Zhang J; Feng H; Chen Z
PLoS Biol; 2019 Jun; 17(6):e3000311. PubMed ID: 31233493
[TBL] [Abstract][Full Text] [Related]
10. Expression and (Lacking) Internalization of the Cell Surface Receptors of
Schöttelndreier D; Seeger K; Grassl GA; Winny MR; Lindner R; Genth H
Front Microbiol; 2018; 9():1483. PubMed ID: 30022975
[TBL] [Abstract][Full Text] [Related]
11. CSPG4-dependent cytotoxicity for
Doyle DA; DeAngelis PL; Ballard JD
mSphere; 2024 Apr; 9(4):e0009424. PubMed ID: 38470254
[TBL] [Abstract][Full Text] [Related]
12. Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027.
Peng Z; Simeon R; Mitchell SB; Zhang J; Feng H; Chen Z
mSphere; 2019 Oct; 4(5):. PubMed ID: 31578248
[No Abstract] [Full Text] [Related]
13. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.
Tao L; Zhang J; Meraner P; Tovaglieri A; Wu X; Gerhard R; Zhang X; Stallcup WB; Miao J; He X; Hurdle JG; Breault DT; Brass AL; Dong M
Nature; 2016 Oct; 538(7625):350-355. PubMed ID: 27680706
[TBL] [Abstract][Full Text] [Related]
14. Receptor binding mechanisms of Clostridioides difficile toxin B and implications for therapeutics development.
Chen P; Jin R
FEBS J; 2023 Feb; 290(4):962-969. PubMed ID: 34862749
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for recognition of frizzled proteins by
Chen P; Tao L; Wang T; Zhang J; He A; Lam KH; Liu Z; He X; Perry K; Dong M; Jin R
Science; 2018 May; 360(6389):664-669. PubMed ID: 29748286
[No Abstract] [Full Text] [Related]
17. Toxin B Variants from
López-Ureña D; Orozco-Aguilar J; Chaves-Madrigal Y; Ramírez-Mata A; Villalobos-Jimenez A; Ost S; Quesada-Gómez C; Rodríguez C; Papatheodorou P; Chaves-Olarte E
Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212980
[No Abstract] [Full Text] [Related]
18. Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for
Childress KO; Cencer CS; Tyska MJ; Lacy DB
mBio; 2023 Oct; 14(5):e0185723. PubMed ID: 37747247
[TBL] [Abstract][Full Text] [Related]
19. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
[TBL] [Abstract][Full Text] [Related]
20. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.
Lanis JM; Barua S; Ballard JD
PLoS Pathog; 2010 Aug; 6(8):e1001061. PubMed ID: 20808849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
